| Authors: |
Marchetti F; Health Canada, Ottawa, ON, Canada., Cardoso R; MilliporeSigma, Rockville, MD, USA., Chen CL; Health and Environmental Sciences Institute, Washington, DC, USA. Electronic address: cchen@hesiglobal.org., Douglas GR; Health Canada, Ottawa, ON, Canada., Elloway J; Safety Sciences, Clinical Pharmacology & Safety Sciences, R&D, AstraZeneca, Cambridge, UK., Escobar PA; Merck & Co., Rahway, NJ, USA., Harper T Jr; Amgen Research, Amgen Inc, Thousand Oaks, CA, USA., Heflich RH; US Food and Drug Administration/National Center for Toxicological Research, Jefferson, AR, USA., Kidd D; Labcorp Early Development Laboratories Limited, Harrogate, North Yorkshire, UK., Lynch AM; GSK R&D, Stevenage, UK., Myers MB; US Food and Drug Administration/National Center for Toxicological Research, Jefferson, AR, USA., Parsons BL; US Food and Drug Administration/National Center for Toxicological Research, Jefferson, AR, USA., Salk JJ; TwinStrand Biosciences Inc., Seattle, WA, USA., Settivari RS; Corteva Agriscience, Newark, DE, USA., Smith-Roe SL; NIEHS, Division of the National Toxicology Program, Research Triangle Park, NC, USA., Witt KL; NIEHS, Division of the National Toxicology Program, Research Triangle Park, NC, USA., Yauk CL; University of Ottawa, Ottawa, ON, Canada., Young R; MilliporeSigma, Rockville, MD, USA; Current: Consultant, Bethesda, MD, USA., Zhang S; Pfizer Inc., Groton, CT, USA., Minocherhomji S; Amgen Research, Amgen Inc, Thousand Oaks, CA, USA; Current: Eli Lilly and Company, Indianapolis, IN, USA. |
